Covid19
Showing NaN - NaN of 43
SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination
Active, not recruiting
- SARS-CoV Infection
- Covid19
- SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
- +5 more
-
Birmingham, Alabama
- +155 more
Dec 16, 2022
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Covid19, Coronavirus, Cancer Trial in United States (Aerobic Exercise Therapy)
Active, not recruiting
- Covid19
- +2 more
- Aerobic Exercise Therapy
-
Basking Ridge, New Jersey
- +6 more
Dec 6, 2022
COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients
Completed
- Multiple Sclerosis
- Covid19
-
New York, New YorkNYU Langone Health
Nov 2, 2022
Covid19 Trial (No video, Video Text)
Recruiting
- Covid19
- No video
- Video Text
-
New York, New YorkOnPoint NYC
Oct 11, 2022
COVID-19 Respiratory Outcomes Registry
Active, not recruiting
- Covid19
- Questionnaires and Patient Reported Outcomes (PROs)
- +10 more
-
Saint Louis, Missouri
- +3 more
Oct 11, 2022
COVID-19 Citizen Science Expansion Project
Enrolling by invitation
- Covid19
-
Sacramento, California
- +8 more
Sep 30, 2022
Blood Volume Assessment in COVID-19 and Bacterial Sepsis
Recruiting
- Covid19
- +3 more
- BVA-100
- +2 more
-
New York, New YorkNYU Langone Health
Aug 16, 2022
Vocalized, Individual Digital Cough Sound Recordings to Screen
Recruiting
- Covid19
- Recordings of cough sounds from adults
-
New York, New YorkStrategy Health LLC
Aug 3, 2022
Covid19 Trial in New York (C144-LS and C-135-LS)
Completed
- Covid19
- C144-LS and C-135-LS
-
New York, New YorkThe Rockefeller University
Aug 2, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,
Terminated
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Newport Beach, California
- +14 more
Jul 20, 2022
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Cognitive Dysfunction, Covid19 Trial in New York (AKL-T01)
Recruiting
- Cognitive Dysfunction
- Covid19
- AKL-T01
-
New York, New YorkWeill Cornell Medicine
Jun 29, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes
Recruiting
- Covid19
- +3 more
-
New York, New YorkWeill Cornell Medicine
Jun 3, 2022
COPD, Chronic Cough, Covid19 Trial in New York (HCFWO, Standard Care Plus Monitoring)
Terminated
- Chronic Obstructive Pulmonary Disease
- +2 more
- HCFWO
- Standard Care Plus Monitoring
-
New York, New YorkMount Sinai Beth Israel
Apr 29, 2022